Evidence map›Paper›PMID 20172680›Full record

ArticleJournal of pharmaceutical and biomedical analysis2010

Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids--quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry.

Ravinder Earla, Sai H S Boddu, Kishore Cholkar, Sudharshan Hariharan, Jwala Jwala, Ashim K Mitra

Abstract readComparative Study
In one paragraph

Article in Journal of pharmaceutical and biomedical analysis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).International journal of pharmaceutics · 2016
    Article
  5. Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2015
    Article
  6. Discovery of novel inhibitors for the treatment of glaucoma.Expert opinion on drug discovery · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ravinder EarlaDivision of Pharmaceutical Sciences, School of Pharmacy, 5258 Health Science Building, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108-2718, USA.
Sai H S Boddu
Kishore Cholkar
Sudharshan Hariharan
Jwala Jwala
Ashim K Mitra

Funding

Ocular Disposition of Antimicrobial AgentsR01EY009171 · NEI · UNIVERSITY OF MISSOURI KANSAS CITY · PI MITRA, ASHIM K. · 1992 to 2010
$3.0M
Transscleral Transport & Polymeric Delivery of Antibody & Steroids for Macular EdR01EY010659 · NEI · UNIVERSITY OF MISSOURI KANSAS CITY · PI MITRA, ASHIM K. · 1996 to 2010
$2.5M
NEI NIH HHS R01 EY009171NEI NIH HHS R01 EY010659NEI NIH HHS R01 EY 09171-12NEI NIH HHS R01 EY 10659-10
6 · The paper itself

Abstract

A sensitive, selective, accurate and robust LC-MS/MS method was developed and validated for the quantitative determination of glucocorticoids in rabbit ocular tissues. Samples were processed by a simple liquid-liquid extraction procedure. Chromatographic separation was performed on Phenomenex reversed phase C18 gemini column (50mmx4.6mm i.d.,) with an isocratic mobile phase composed of 30% of acetonitrile in water containing 0.1% of formic acid, at a flow rate 0.2mL/min. Dexamethasone (DEX), prednisolone (PD) and hydrocortisone (HD) were detected with proton adducts at m/z 393.20-->355.30, 361.30-->147.20 and 363.20-->121.0 in multiple reaction monitoring (MRM) positive mode respectively. Finally, 50microL of 0.1% novel DEX mixed micellar formulation was topically administered to a rabbit eye and concentrations were measured. The method was validated over a linear concentration range of 2.7-617.6ng/mL. Lower limit of quantitation (LLOQ) of DEX and PD was measured in the concentration range of 2.7 and 11.0ng/mL respectively. The resulting method demonstrated intra and inter-day precision within 13.3% and 11.1% and accuracy within 19.3% and 12.5% for DEX and PD, respectively. Both analytes were found to be stable throughout freeze-thaw cycles and during bench top and postoperative stability studies (r(2)>0.999). DEX concentrations in various ocular tissue samples i.e., aqueous humor, cornea, iris ciliary body, sclera and retina choroid were found to be 344.0, 1050.07, 529.6, 103.9 and 48.5ng/mg protein respectively. Absorption of DEX after topical administration from a novel aqueous mixed micellar formulation achieved therapeutic concentration levels in posterior segment of the rabbit eye.

Indexed as

AnimalsChromatography, LiquidDexamethasoneDrug Evaluation, PreclinicalEyeGlucocorticoidsMaleRabbitsReproducibility of ResultsTandem Mass SpectrometryDexamethasoneGlucocorticoids

Identifiers

PMID20172680
PMCPMC2853008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.